"Thrombocytopenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subnormal level of BLOOD PLATELETS.
| Descriptor ID |
D013921
|
| MeSH Number(s) |
C15.378.140.855
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thrombocytopenia".
Below are MeSH descriptors whose meaning is more specific than "Thrombocytopenia".
This graph shows the total number of publications written about "Thrombocytopenia" by people in this website by year, and whether "Thrombocytopenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 2 | 3 |
| 2014 | 0 | 1 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thrombocytopenia" by people in Profiles.
-
Vaccine-induced immune thrombotic thrombocytopenia: why, what, who, and how? Am J Emerg Med. 2022 Jul; 57:158-159.
-
Valproic Acid Serum Concentration and Incidence of Toxicity in Pediatric Patients. J Child Neurol. 2022 05; 37(6):461-470.
-
Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. Am J Emerg Med. 2021 Nov; 49:58-61.
-
Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States. Aliment Pharmacol Ther. 2020 10; 52(8):1311-1322.
-
Impact of chronic thrombocytopenia on in-hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 08; 96(2):413-421.
-
Triplet therapies - the new standard of care for multiple myeloma: how to manage common toxicities. Expert Rev Hematol. 2018 12; 11(12):957-973.
-
Nutrition Support for Critically Ill Patients With Cancer. Nutr Clin Pract. 2017 Oct; 32(5):578-586.
-
A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1166-71.
-
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer. Clin Cancer Res. 2012 Jun 01; 18(11):3163-9.
-
Anticoagulants: therapeutics, risks, and toxicity--special emphasis on heparin-induced thrombocytopenia (HIT). J Pharm Pract. 2012 Feb; 25(1):22-9.